FULCRUM THERAPEUTICS
3.6700
07-أكتوبر-24 10:06:16
15 متأخرة بدقائق
الأسهم
-0.1500
-3.93%
نطاق اليوم
3.6200 - 3.7800
ISIN
N/A
المصدر
NASDAQ
-
15 مايو 2023 07:05:00 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Appoints Alex C. Sapir Chief Executive Officer
15 مايو 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
08 مايو 2023 16:05:01 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 مايو 2023 18:06:50 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 أبريل 2023 17:00:00 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces CFO Resignation
05 أبريل 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 مارس 2023 17:00:00 بحسب Nasdaq GlobeNewswire
-
09 مارس 2023 07:00:01 بحسب Nasdaq GlobeNewswire
-
06 مارس 2023 16:05:00 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Clinical Hold on FTX-6058 in Sickle Cell Disease
24 فبراير 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 فبراير 2023 17:27:22 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate at the Upcoming SVB Securities Global Biopharma Conference
08 فبراير 2023 17:00:00 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
17 يناير 2023 23:15:16 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
17 يناير 2023 16:01:00 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 يناير 2023 17:00:00 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Provides Business Update and 2023 Outlook
04 يناير 2023 07:02:00 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces CEO Transition
04 يناير 2023 07:01:00 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 ديسمبر 2022 17:20:59 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate at Upcoming 2022 BofA Securities Biotech SMID Cap Conference
01 ديسمبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 نوفمبر 2022 18:33:20 بحسب Nasdaq GlobeNewswire